Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

incyte

Incyte acquires Ariad’s European operations in $140 million deal

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Ariad, Incyte, Operations, buy out, european, iclusig, leukaemia, out-license

Incyte (NASDAQ: INCY) has entered into an agreement with Ariad Pharmaceuticals (NASDAQ: ARIA) that will see the company acquire Ariad’s …
News
celltherapy

Cell Therapy signs £12.5 million licensing deal with Daiichi Sankyo for heart failure treatment

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo, Deals, cell therapy, heart failure, licensing

UK-based Cell Therapy on Tuesday said it has signed a £12.5 million licensing deal with Japan’s Daiichi Sankyo (TYO: 4568) …
News
medivation

Medivation maybe mulling sale as bidding race heats up – Reports

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Deals, M&A, MA, Medivation, Pfizer, Sanofi

Cancer drugmaker Medivation (Nasdaq: MDVN) is evaluating a potential sale following the recent string of offers from big pharma firms, …
News
vaccination

Takeda secures $38 million grant to develop affordable polio vaccine

May 10, 2016 Manufacturing and Production, Research and Development Bill and Melinda Gates Foundation, Gates Foundation, Takeda, Vaccine, access, developing countries, grant, polio

Takeda Pharmaceuticals has received a $38 million grant from the Bill and Melinda Gates Foundation to develop a low-cost polio …
News

Scottish Medicines Consortium does not back Vertex’ cystic fibrosis drugs Orkambi, Kalydeco

May 10, 2016 Manufacturing and Production, Research and Development Kalydeco, Orkambi, SMC, Vertex Pharma, cystic fibrosis, regulation

The Scottish Medicines Consortium did not back two cystic fibrosis therapies from Vertex Pharmaceutical (Nasdaq: VRTX).  SMC did not recommend …
News
cancer_cells

Second child cleared of leukaemia after Cellectis T-cell treatment

May 10, 2016 Manufacturing and Production, Research and Development cellecits, childhood, children, designer cells, leukaemia, rare, t cells, t-cells

A targeted T-cell oncology therapy has successfully treated a second baby with aggressive leukaemia who has remained in remission after …
News

China evaluating investigations into pharma firms to take on drug pricing issue

May 9, 2016 Business Services, Research and Development, Sales and Marketing China, France, G7, regulation

Lawmakers globally have acknowledged the concerns over unbridled drug costs as regulators stress the need for a more open debate …
News
abpi_reception_right

UK pharma would benefit by remaining in EU, says ABPI

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Andrew Witty, EU, brexit, letter, observer, pascal soriot, remain, stay

With the EU vote approaching, the Association of the British Pharmaceutical Industry (ABPI) has brought together 93 signatories, including the …
News
shutterstock_67313209

Focus: Governments evaluate policies, reforms as drug pricing debate rages on

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

By Anjali Shukla Lawmakers in France are set to urge the leaders of G7 countries to put in place guidelines …
Feature
needles

BTG acquires promising oncology pipeline in Galil Medical takeover

May 9, 2016 Manufacturing and Production, Research and Development, Sales and Marketing $84 million, BTG, cryoablation, galil medical, oncology, takeover

BTG (LSE: BTG) has announced that is has agreed to acquire Galil Medical, a leading provider of cryoablation products for …
News
allergan

Phase III trial meets primary endpoint for Allergan’s fibroid treatment

May 9, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Allergan, fibroid, phase 3, phase III, ulipristal, ulipristal acetate, uterine fibroid

Allergan (NYSE: AGN), in collaboration with Gedeon Richter, has announced positive results from a pivotal Phase III trial evaluating the …
News
stocks1

Weekly Movers: Bind Therapeutics, Sarepta, Idexx…

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer (NYSE: PFE) and Amgen (Nasdaq: AMGN) are rumoured to be considering a bid for Medivation just as French drug …
Feature
stocks2

Clovis cuts staff by 35% after FDA knock back on lung cancer drug

May 6, 2016 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Q1 results, clovis, failure, job cuts, job losses, rociletinib, workforce

Clovis Oncology (NASDAQ: CLVS) is set to cut up to 35% of its workforce following the US Food and Drug …
News
tug-of-war

Focus: Medivation tug-of-war rumbles on

May 6, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, AstraZeneca, Medivation, Pfizer, Sanofi, billion dollar, competition, oncology, pipeline, promising, takeover, tug of war

Medivation (NASDAQ: MDVN) has been making all the headlines as a list of suitors’ line up, all vying to secure …
Feature
pfizerbrussels

Pfizer teams up with Wave Life Sciences for metabolic disease research

May 6, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, metabolic disease, nucelic acid therapies, partnership, wave life sciences

Pfizer (NYSE: PFE) has entered into a research, license and option agreement with Wave Life Sciences (NASDAQ: WVE) for the …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026